• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终身累计活动负担与致心律失常性右心室心肌病患者的症状性心力衰竭和心律失常风险相关:一项回顾性队列研究。

Lifetime cumulative activity burden is associated with symptomatic heart failure and arrhythmic risk in patients with arrhythmogenic right ventricular cardiomyopathy: a retrospective cohort study.

机构信息

Department of Medicine I, LMU University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, Germany.

DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Pettenkoferstraße 8a/9, 80336 Munich, Germany.

出版信息

Europace. 2024 Oct 3;26(10). doi: 10.1093/europace/euae236.

DOI:10.1093/europace/euae236
PMID:39305246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11481332/
Abstract

AIMS

Sports-related physical activity is associated with an increased risk of ventricular dysfunction and arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). However, there are currently no standardized strategies for activity assessment. Thresholds for harmful levels of physical activity suggested by previous studies vary substantially and neither lifetime activity burden nor continuous modelling approaches were considered.

METHODS AND RESULTS

For this single-centre retrospective study, ARVC patients were interviewed to assess sports-related and non-sports-related physical activity between the age of 10 years and the last follow-up. Activity data were aggregated to the median metabolic equivalent of task-hours (METh) per week for each year. The association between cumulative physical activity burden and clinical study endpoints was investigated using Cox regression models. A total of 124 patients (median age: 39.5 years, 48% male) were included in the analysis, of whom 93 had been diagnosed with definite ARVC. Study participants reported a median overall activity of 202.3 METh/week, with 38.7 METh/week attributed to sports-related activity. In the continuous model, cumulative overall activity burden was associated with the occurrence of symptomatic heart failure [hazard ratio (HR) per 100 METh/week: 1.017, 95% CI (1.003, 1.032), P = 0.015], sustained ventricular tachycardia [HR: 1.021, 95% CI (1.006, 1.037), P = 0.007], and implantable cardioverter defibrillator interventions [HR: 1.017, 95%CI (1.000, 1.034), P = 0.048]. This finding was consistent when considering sports-related activity separately as a predictor variable, whereas the resulting hazard ratios did not show a significant association for non-sports-related physical activity.

CONCLUSION

This study demonstrates for the first time that cumulative physical activity as a continuous predictor variable is associated with symptomatic heart failure and arrhythmic risk in ARVC patients. Collaborative research is required in larger cohorts to investigate the influence of potential confounders on event occurrence and to develop threshold recommendations for clinical practice.

摘要

目的

运动相关的体力活动与致心律失常性右室心肌病(ARVC)患者的心室功能障碍和心律失常风险增加相关。然而,目前尚无评估活动的标准化策略。之前的研究中建议的有害体力活动水平的阈值差异很大,而且既没有考虑终生活动负担,也没有考虑连续建模方法。

方法和结果

这项单中心回顾性研究对 ARVC 患者进行了访谈,以评估 10 岁至最后一次随访期间的运动相关和非运动相关体力活动。将活动数据汇总到每周每代谢当量任务小时(METh)的中位数。使用 Cox 回归模型研究累积体力活动负担与临床研究终点之间的关系。共纳入 124 名患者(中位年龄:39.5 岁,48%为男性)进行分析,其中 93 名被诊断为明确的 ARVC。研究参与者报告的总体活动中位数为 202.3 METh/周,其中 38.7 METh/周归因于运动相关活动。在连续模型中,累积总体活动负担与症状性心力衰竭的发生相关[每 100 METh/周的危险比(HR):1.017,95%置信区间(CI)(1.003,1.032),P = 0.015],持续性室性心动过速[HR:1.021,95%CI(1.006,1.037),P = 0.007]和植入式心脏复律除颤器干预[HR:1.017,95%CI(1.000,1.034),P = 0.048]。当分别将运动相关活动视为预测变量时,这一发现是一致的,而由此产生的危险比对于非运动相关体力活动没有显示出显著的相关性。

结论

这项研究首次表明,作为连续预测变量的累积体力活动与 ARVC 患者的症状性心力衰竭和心律失常风险相关。需要在更大的队列中进行协作研究,以调查潜在混杂因素对事件发生的影响,并为临床实践制定阈值建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d5/11481332/c3568a36f65e/euae236f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d5/11481332/9a9e47d9d0c9/euae236_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d5/11481332/7bb3dac80799/euae236f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d5/11481332/c3568a36f65e/euae236f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d5/11481332/9a9e47d9d0c9/euae236_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d5/11481332/7bb3dac80799/euae236f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15d5/11481332/c3568a36f65e/euae236f2.jpg

相似文献

1
Lifetime cumulative activity burden is associated with symptomatic heart failure and arrhythmic risk in patients with arrhythmogenic right ventricular cardiomyopathy: a retrospective cohort study.终身累计活动负担与致心律失常性右心室心肌病患者的症状性心力衰竭和心律失常风险相关:一项回顾性队列研究。
Europace. 2024 Oct 3;26(10). doi: 10.1093/europace/euae236.
2
Integrating Exercise Into Personalized Ventricular Arrhythmia Risk Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy.将运动融入致心律失常性右心室心肌病的个体化室性心律失常风险预测中。
Circ Arrhythm Electrophysiol. 2022 Feb;15(2):e010221. doi: 10.1161/CIRCEP.121.010221. Epub 2022 Jan 28.
3
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.致心律失常性右室心肌病:临床过程和心律失常风险的预测因素。
J Am Coll Cardiol. 2016 Dec 13;68(23):2540-2550. doi: 10.1016/j.jacc.2016.09.951.
4
Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.致心律失常性右室心肌病/发育不良患者的风险分层,无需植入式心脏复律除颤器。
JACC Clin Electrophysiol. 2018 Jun;4(6):757-768. doi: 10.1016/j.jacep.2018.04.017.
5
Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.表型表达是致心律失常性右室心肌病发生恶性心律失常事件和心源性猝死的前提条件。
Europace. 2016 Jul;18(7):1086-94. doi: 10.1093/europace/euv205. Epub 2015 Jul 2.
6
Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis.致心律失常性右室心肌病中心律失常性猝死的发生率及预测因素:一项汇总分析。
Europace. 2022 Oct 13;24(10):1665-1674. doi: 10.1093/europace/euac014.
7
Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.致心律失常性右室心肌病的风险分层
Circulation. 2017 Nov 21;136(21):2068-2082. doi: 10.1161/CIRCULATIONAHA.117.030792.
8
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment.致心律失常性右室心肌病的终身心律失常风险分层:事件分布及定期重新评估的影响。
Europace. 2018 Jun 1;20(FI1):f20-f29. doi: 10.1093/europace/eux093.
9
Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators.致心律失常性右室心肌病患者在未植入除颤器情况下的心律失常结局。
J Cardiovasc Electrophysiol. 2018 Oct;29(10):1396-1402. doi: 10.1111/jce.13668. Epub 2018 Jun 27.
10
Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.预测致心律失常性右室心肌病的心律失常风险:系统评价和荟萃分析。
Heart Rhythm. 2018 Jul;15(7):1097-1107. doi: 10.1016/j.hrthm.2018.01.031. Epub 2018 Feb 3.

本文引用的文献

1
New Diagnostic Approach to Arrhythmogenic Cardiomyopathy: The Padua Criteria.致心律失常性心肌病的新诊断方法:帕多瓦标准。
Rev Cardiovasc Med. 2022 Oct 10;23(10):335. doi: 10.31083/j.rcm2310335. eCollection 2022 Oct.
2
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers.一种用于桥粒芯蛋白基因突变携带者心律失常风险分层的新工具。
Eur Heart J. 2024 Aug 21;45(32):2968-2979. doi: 10.1093/eurheartj/ehae409.
3
Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular Cardiomyopathy.
桥粒斑蛋白相关致心律失常性右室心肌病患者的长期心律失常随访及危险分层
JACC Adv. 2024 Feb 2;3(3):100832. doi: 10.1016/j.jacadv.2024.100832. eCollection 2024 Mar.
4
Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry.儿童和青少年心肌病:欧洲心脏病学会 EURObservational Research Programme 心肌病和心肌炎注册研究的病因、治疗和结局。
Eur Heart J. 2024 Apr 21;45(16):1443-1454. doi: 10.1093/eurheartj/ehae109.
5
Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic Cardiomyopathies.致心律失常性右室心肌病患者的表型表达和临床结局。
J Am Coll Cardiol. 2024 Feb 27;83(8):797-807. doi: 10.1016/j.jacc.2023.12.015.
6
Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy.心律失常性右室心肌病的心律失常风险分层。
Europace. 2023 Nov 2;25(11). doi: 10.1093/europace/euad312.
7
Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report.致心律失常性心肌病的拟议诊断标准:欧洲工作组共识报告。
Int J Cardiol. 2024 Jan 15;395:131447. doi: 10.1016/j.ijcard.2023.131447. Epub 2023 Oct 14.
8
Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion.右心室功能是致心律失常性右室心肌病需要抗心动过速起搏的持续性室性心动过速的预测因子:经静脉与皮下植入式心脏复律除颤器置入的比较。
Europace. 2023 May 19;25(5). doi: 10.1093/europace/euad073.
9
Scarring/arrhythmogenic cardiomyopathy.瘢痕形成/致心律失常性心肌病
Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C144-C154. doi: 10.1093/eurheartjsupp/suad017. eCollection 2023 May.
10
Progressive Reduction in Right Ventricular Contractile Function Attributable to Altered Actin Expression in an Aging Mouse Model of Arrhythmogenic Cardiomyopathy.致心律失常性心肌病衰老小鼠模型中肌动蛋白表达改变导致右心室收缩功能进行性下降。
Circulation. 2022 May 24;145(21):1609-1624. doi: 10.1161/CIRCULATIONAHA.120.049261. Epub 2022 Apr 19.